Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer

Oncology Letters
Masahiro ItoYoshiyuki Nakajima

Abstract

Tripartite motif protein (TRIM) 32 belongs to the TRIM family, which is composed of RING finger, B-box and coiled-coil domains. TRIM32 has been reported to function as an enzyme 3 ubiquitin ligase and is overexpressed in numerous types of cancer. The present study evaluated the clinical significance of TRIM32 expression levels in gastric cancer. The current study also investigated the TRIM32 expression levels in 142 patients with gastric cancer using immunohistochemistry and examined its clinical importance and potential as a prognostic marker. Furthermore, the function of TRIM32 was examined in vitro. High TRIM32 expression levels were detected in gastric cancer tissues. The postoperative overall and relapse-free survival rates were significantly reduced in patients with tumors with high levels of TRIM32 expression compared with those with tumors expressing low levels of TRIM32. Tumors expressing high levels of TRIM32 were associated with an increased risk of postoperative recurrence, particularly hematogenous recurrence. Multivariate analysis identified TRIM32 status as an independent prognostic factor. Furthermore, TRIM32 gene silencing induced apoptosis and inhibited the proliferation of gastric cancer cells in vitro. There...Continue Reading

References

Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
May 2, 2001·The EMBO Journal·A ReymondA Ballabio
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Jun 29, 2007·Annals of Surgical Oncology·Yoshimasa KosakaMasaki Mori
Feb 2, 2008·Science·Michael R SchlabachStephen J Elledge
Nov 19, 2008·The British Journal of Surgery·P SunZ-Y Chen
Jun 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kendra AlltonMichelle Craig Barton
Jun 27, 2009·Cell Death and Differentiation·A G Eldridge, T O'Brien
Nov 10, 2009·Annals of Surgical Oncology·Takeshi YokoeMasato Kusunoki
Jun 6, 2012·Annual Review of Biochemistry·Alexander Varshavsky
Jan 26, 2013·Cancer Science·Yang YeJianwei Zhou
Aug 13, 2013·Oncology Reports·Genta SawadaKoshi Mimori
Dec 3, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kazuhiro MigitaYoshiyuki Nakajima

❮ Previous
Next ❯

Citations

Aug 7, 2018·Journal of Cellular and Molecular Medicine·Changming WangQingping Cai
Nov 1, 2018·Journal of Cellular Biochemistry·Hongmei YinXiaobo Hu
Apr 1, 2020·Frontiers in Pharmacology·Michael A MandellTodd A Thompson
Apr 1, 2020·ELife·Simranjot BawaErika R Geisbrecht
Jan 5, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Huizhen WangYongxiang Li
Jun 29, 2021·Genes & Diseases·Juan LiuZhaohui Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.